The Effect of Paracetamol, Pseudoephedrine Hydrochloride, Dextromethorphan Hydrobromide and Chlorpheniramine Maleate Tablets Compared to Placebo in Subjects Suffering From the Common Cold or Influenza.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
With
Sino-American Tianjin Smith Kline & French Laboratories Ltd
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Aged at least 18 years and less than 65 years
Good general and mental health in the opinion of the investigator
Participants diagnosed with a common cold or flu and must have the following symptoms of at least "moderate" in intensity (≥ 2) at the screening visit (baseline), with a minimum total symptom score of 6:
(i) At least one of pain symptoms: sore throat, headache, or extremities pain (ii) Mandatory: Nasal congestion (iii) At least one of catarrh symptoms: runny nose or sneezing
Onset of first symptoms of cold must have occurred within 48 hours of screening.
You may not be if
Pregnant or breast feeding women
History of seasonal or perennial allergic rhinitis or acute, sub-chronic, or chronic cough due to any condition other than a common cold or flu, as determined by the investigator
Concurrent illness or medical history that is contraindicated or cautioned about in the drug label
Anatomical factors causing nasal congestion
Fever with body temperature \>38.5°C at baseline
Have used any medication or herbal remedies to treat cold prior to screening (antibiotics in the last 7 days, antihistamines in the last 72 hours, analgesics or antipyretics in the last 24 hours, decongestant in the last 12 hours, antitussive, medicated lozenge or throat spray in the last 8 hours)
Any medication that has potential drug-drug interactions with study medications
Known or suspected intolerance or hypersensitivity to the study materials
Have a positive drug urine test or recent history (within the last 2 years) of alcohol or other substance abuse